The Coronavirus Disease 2019 Spatial Care Path: Home, Community, and Emergency Diagnostic Portals
Open accessPublished version of a preprint
The DOI matches its Crossref record; 109 of the 111 references it cites were found in a registry or an index.
Abstract
This research uses mathematically derived visual logistics to interpret COVID-19 molecular and rapid antigen test (RAgT) performance, determine prevalence boundaries where risk exceeds expectations, and evaluate benefits of recursive testing along home, community, and emergency spatial care paths. Mathematica and open access software helped graph relationships, compare performance patterns, and perform recursive computations. Tiered sensitivity/specificity comprise: (T1) 90%/95%; (T2) 95%/97.5%; and (T3) 100%/≥99%, respectively. In emergency medicine, median RAgT performance peaks at 13.2% prevalence, then falls below T1, generating risky prevalence boundaries. RAgTs in pediatric ERs/EDs parallel this pattern with asymptomatic worse than symptomatic performance. In communities, RAgTs display large uncertainty with median prevalence boundary of 14.8% for 1/20 missed diagnoses, and at prevalence > 33.3–36.9% risk 10% false omissions for symptomatic subjects. Recursive testing improves home RAgT performance. Home molecular tests elevate performance above T1 but lack adequate validation. Widespread RAgT availability encourages self-testing. Asymptomatic RAgT and PCR-based saliva testing present the highest chance of missed diagnoses. Home testing twice, once just before mingling, and molecular-based self-testing, help avoid false omissions. Community and ER/ED RAgTs can identify contagiousness in low prevalence. Real-world trials of performance, cost-effectiveness, and public health impact could identify home molecular diagnostics as an optimal diagnostic portal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PB analysis indicates that, in order to avoid spreading disease with false negatives, RAgTs should achieve an initial sensitivity of at least 91.0 -91.4 % [76, 77] and Tier-3 speci fi city of ≥ 99 %.”
From Point-of-care testing: state-of-the art and perspectives (2025) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tiered sensitivity/speci fi city comprise: Tier-1) 90 %, 95 %; Tier-2) 95 %, 97.5 %; and Tier-3) 100 %, ≥ 99 %, respectively [74 -77].”
From Point-of-care testing: state-of-the art and perspectives (2025) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, H., Paulson, K. R., Pease, S. A., Watson, S., Comfort, H., Zheng, P., Aravkin, A. Y., Bisignano, C., Barber, R. M., Alam, T., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02796-3 · Cited by 2,069
Nagura-Ikeda, M., Imai, K., Tabata, S., Miyoshi, K., Murahara, N., Mizuno, T., Horiuchi, M., Kato, K., Imoto, Y., Iwata, M., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01438-20 · Cited by 397
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Vogels, C. B. F., Watkins, A. E., Harden, C. A., Brackney, D. E., Shafer, J., Wang, J., Caraballo, C., Kalinich, C. C., Ott, I. M., Fauver, J. R., et al. (2021) · Med · doi:10.1016/j.medj.2020.12.010 · Cited by 306
Van Vinh Chau, N., Lam, V. T., Dung, N. T., Yen, L. M., Minh, N. N. Q., Hung, L. M., Ngoc, N. M., Dung, N. T., Man, D. N. H., Nguyet, L. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa711 · Cited by 243
Linares, M., Pérez-Tanoira, R., Carrero, A., Romanyk, J., Pérez-García, F., Gómez-Herruz, P., Arroyo, T., & Cuadros, J. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104659 · Cited by 236
Prince-Guerra, J. L., Almendares, O., Nolen, L. D., Gunn, J. K. L., Dale, A. P., Buono, S. A., Deutsch-Feldman, M., Suppiah, S., Hao, L., Zeng, Y., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7003e3 · Cited by 214
Cerutti, F., Burdino, E., Milia, M. G., Allice, T., Gregori, G., Bruzzone, B., & Ghisetti, V. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104654 · Cited by 197
Gremmels, H., Winkel, B. M. F., Schuurman, R., Rosingh, A., Rigter, N. A. M., Rodriguez, O., Ubijaan, J., Wensing, A. M. J., Bonten, M. J. M., & Hofstra, L. M. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100677 · Cited by 176
Pilarowski, G., Lebel, P., Sunshine, S., Liu, J., Crawford, E., Marquez, C., Rubio, L., Chamie, G., Martinez, J., Peng, J., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa802 · Cited by 164
Pollock, N. R., Jacobs, J. R., Tran, K., Cranston, A. E., Smith, S., Kane, C. O., Roady, T. J., Moran, A., Scarry, A., Carroll, M., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00083-21 · Cited by 146
Yokota, I., Shane, P. Y., Okada, K., Unoki, Y., Yang, Y., Inao, T., Sakamaki, K., Iwasaki, S., Hayasaka, K., Sugita, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1388 · Cited by 144
Boum, Y., Fai, K. N., Nikolay, B., Akenji, B., Bebell, L. M., Ndifon, M., Abbah, A., Essaka, R., Eteki, L., Luquero, F. J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00132-8 · Cited by 102
Nalumansi, A., Lutalo, T., Kayiwa, J. T., Watera, C., Balinandi, S. K., Kiconco, J., Nakaseegu, J., Olara, D., Odwilo, E., Serwanga, J., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.073 · Cited by 96
Fernandez-Montero, A., Argemi, J., Rodríguez, J. A., Ariño, A. H., & Moreno-Galarraga, L. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.100954 · Cited by 88
García‐Fiñana, M., Hughes, D. M., Cheyne, C. P., Burnside, G., Stockbridge, M., Fowler, T., Fowler, V. L., Wilcox, M. H., Semple, M. G., & Buchan, I. E. (2021) · BMJ · doi:10.1136/bmj.n1637 · Cited by 86
SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department
Möckel, M., Corman, V. M., Stegemann, M. S., Hofmann, J., Stein, A., Jones, T. C., Gastmeier, P., Seybold, J., Offermann, R., Bachmann, U., et al. (2021) · Biomarkers · doi:10.1080/1354750x.2021.1876769 · Cited by 85
Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting
Osterman, A., Baldauf, H., Eletreby, M., Wettengel, J. M., Afridi, S. Q., Fuchs, T., Holzmann, E., Maier, A., Döring, J., Grzimek-Koschewa, N., et al. (2021) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00698-8 · Cited by 82
Stohr, J., Zwart, V. F., Goderski, G., Meijer, A., Nagel-Imming, C. R. S., den Bergh, M. K.-V., Pas, S. D., van den Oetelaar, F., Hellwich, M., Gan, K. H., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.07.039 · Cited by 73
Drain, P. K., Ampajwala, M., Chappel, C., Gvozden, A. B., Hoppers, M., Wang, M., Rosen, R., Young, S. A., Zissman, E. N., & Montaño, M. A. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00413-x · Cited by 72
Babady, N. E., McMillen, T. A., Jani, K., Viale, A. J., Robilotti, E. V., Aslam, A., Diver, M., Sokoli, D., Mason, G., Shah, M. K., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.10.018 · Cited by 70
Frediani, J. K., Levy, J. M., Rao, A., Bassit, L., Figueroa, J., Vos, M. B., Wood, A. R., Jerris, R. C., Leung‐Pineda, V., Gonzalez, M. D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94055-1 · Cited by 69
Villaverde, S., Domínguez‐Rodríguez, S., Sabrido, G., Pérez-Jorge, C., Plata, M., Romero‐Gómez, M. P., Grasa, C. D., Jiménez, A. B., Heras, E. D. L., Broncano-Lavado, A., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.01.027 · Cited by 68
Performance of a rapid antigen test in the diagnosis of SARS‐CoV‐2 infection
Ciotti, M., Maurici, M., Pieri, M., Andreoni, M., & Bernardini, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26830 · Cited by 63
Saliva is a reliable and accessible source for the detection of SARS-CoV-2
Herrera, L. A., Hidalgo‐Miranda, A., Reynoso‐Noverón, N., Meneses-García, A. A., Mendoza-Vargas, A., Reyes‐Grajeda, J. P., Vadillo‐Ortega, F., Cedro‐Tanda, A., Peñaloza, F., Frías-Jiménez, E., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.009 · Cited by 61
Gremmels, H., Winkel, B. M. F., Schuurman, R., et al. (2020) · medRxiv · doi:10.1101/2020.10.16.20214189 · Cited by 58
Masiá, M., Fernández‐González, M., Sánchez-Molla, M., Carvajal, M., García, J. A., Gonzalo-Jiménez, N., de la Tabla, V. O., Agulló, V., Candela, I., Guijarro, J., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab059 · Cited by 55
der Moeren, N. V., Zwart, V. F., Lodder, E. B., van den Bijllaardt, W., Esch, H. R. J. M. V., Stohr, J., Pot, J., Welschen, I., Mechelen, P. M. F. V., Pas, S. D., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250886 · Cited by 53
Donato, L. J., Trivedi, V. A., Stransky, A. M., Misra, A., Pritt, B. S., Binnicker, M. J., & Karon, B. S. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115307 · Cited by 52 · cited 2×
“[8] evaluation of home molecular testing (curve “HMDx”) demonstrated a Tier 1 prevalence boundary of 56.”
Caruana, G., Croxatto, A., Kampouri, E., Kritikos, A., Opota, O., Foerster, M., Brouillet, R., Senn, L., Lienhard, R., Egli, A., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040798 · Cited by 52
Gili, A., Paggi, R., Russo, C. A., Cenci, E., Pietrella, D., Graziani, A., Stracci, F., & Mencacci, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.098 · Cited by 51
Think of the Children: Evaluation of SARS-CoV-2 Rapid Antigen Test in Pediatric Population
González-Donapetry, P., García-Clemente, P., Bloise, I., García-Sánchez, C., Castellano, M. Á. S., Romero‐Gómez, M. P., Gutiérrez-Arroyo, A., Mingorance, J., de Ceano-Vivas, M., & García‐Rodríguez, J. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003101 · Cited by 50
Stokes, W., Berenger, B. M., Portnoy, D., Scott, B. N. V., Szelewicki, J., Singh, T., Venner, A. A., Turnbull, L., Pabbaraju, K., Shokoples, S., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04202-9 · Cited by 46
Practical Guide to Global Point-of-Care Testing
(2016) · CSIRO Publishing eBooks · doi:10.1071/9781486305193 · Cited by 42
Turcato, G., Zaboli, A., Pfeifer, N., Ciccariello, L., Sibilio, S., Tezza, G., & Ausserhofer, D. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.012 · Cited by 42
Shah, M. M., Salvatore, P. P., Ford, L., Kamitani, E., Whaley, M. J., Mitchell, K. F., Currie, D. W., Morgan, C. N., Segaloff, H. E., Lecher, S. L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab309 · Cited by 40
Bohn, M. K., Lippi, G., Horvath, A. R., Erasmus, R. T., Grimmler, M., Gramegna, M., Mancini, N., Mueller, R., Rawlinson, W. D., Menezes, M. E., et al. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0455 · Cited by 39 · cited 1×
“successful implementation of rapid antigen testing protocols must closely consider technical, pre-analytical, analytical and clinical assay performance and interpret and verify test results depending on the pretest-probability of SARS-CoV-2 infection” [98].”
BackgroundA Real-World Comparison of SARS-CoV-2 Rapid Antigen Testing versus PCR Testing in Florida
Allan‐Blitz, L., & Klausner, J. D. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01107-21 · Cited by 39
Kost, G. J. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00329 · Cited by 38
Self-citationGeospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks
Kost, G. J. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0172-ra · Cited by 38 · cited 1×
“This initiative will add to the massive expansion of point-of-care strategies and promote higher quality molecular self-testing [1,2,104,105].”
BackgroundSelf-citationProspective Comparison of Saliva and Nasopharyngeal Swab Sampling for Mass Screening for COVID-19
Nacher, M., Mergeay-Fabre, M., Blanchet, D., Benois, O., Pozl, T., Mesphoule, P., Sainte-Rose, V., Vialette, V., Toulet, B., Moua, A., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.621160 · Cited by 38
Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2
Nsoga, M. T. N., Kronig, I., Rodríguez, F., Sattonnet‐Roche, P., Silva, D. D., Helbling, J., Sacks, J. A., de Vos, M., Boehm, E., Gayet‐Ageron, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253321 · Cited by 35
Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection
Oh, S.-M., Jeong, H., Chang, E., Choe, P. G., Kang, C. K., Park, W. B., Kim, T. S., Kwon, W. Y., Oh, M., & Kim, N. J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e101 · Cited by 33
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection
Bianco, G., Boattini, M., Barbui, A. M., Scozzari, G., Riccardini, F., Coggiola, M., Lupia, E., Cavallo, R., & Costa, C. S. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104838 · Cited by 32
Kernéis, S., Elie, C., Fourgeaud, J., Choupeaux, L., Mercier‐Delarue, S., Alby, M.-L., Quentin, P., Pavie, J., Brazille, P., Néré, M. L., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04327-x · Cited by 32
Turcato, G., Zaboli, A., Pfeifer, N., Sibilio, S., Tezza, G., Bonora, A., Ciccariello, L., & Ausserhofer, D. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.10.022 · Cited by 32
Sensitivity, specificity, and predictive values
Lheureux, P. E. R. (1998) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(98)90077-8 · Cited by 31
Kost, G. J. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1491793 · Cited by 30
Self-citationKost, M., Ferguson, M., Hoe, J., Truong, A.-T., Banpavichit, M., & Kongpila, M. (2015) · American Journal of Disaster Medicine · doi:10.5055/ajdm.2015.0196 · Cited by 29
Self-citationBosworth, A., Whalley, C., Poxon, C., Wanigasooriya, K., Pickles, O. J., Aldera, E. L., Papakonstantinou, D., Morley, G. L., Walker, E. M., Zielinska, A. E., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104469 · Cited by 28
Orsi, A., Pennati, B. M., Bruzzone, B. M., Ricucci, V., Ferone, D., Barbera, P., Arboscello, E., Dentone, C., & Icardi, G. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114201 · Cited by 28
Siddiqui, Z. K., Chaudhary, M., Robinson, M. L., McCall, A. B., Peralta, R., Esteve, R., Callahan, C. W., Manabe, Y. C., Campbell, J. D., Johnson, J. K., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01008-21 · Cited by 28
Jian, M., Perng, C., Chung, H., Chang, C.-K., Lin, J., Yeh, K., Chen, C., Hsieh, S., Pan, P.-C., Chang, H.-T., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.11.034 · Cited by 28
Kost, G. J., Ferguson, W., Truong, A.-T., Hoe, J., Prom, D., Banpavichit, A., & Kongpila, S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1079776 · Cited by 26 · cited 1×
“9] 100 [3, 100] Symptomatic subjects for above”
Self-citationKost, G. J., Zadran, A., Zadran, L., & Ventura, I. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00385 · Cited by 26
Self-citationCarbonell‐Sahuquillo, S., Carreño, M. I. L., Camacho, J., Fernández, A. B., Albert, E., Torres, I., Bretón-Martínez, J. R., Martínez‐Costa, C., & Navarro, D. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27220 · Cited by 26
Leli, C., Matteo, L. D., Gotta, F., Cornaglia, E., Vay, D., Megna, I., Pensato, R. E., Boverio, R., & Rocchetti, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.043 · Cited by 26
The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testingPreprint
Dřevínek, P., Hurych, J., Kepka, Z., Briksí, A., Kulich, M., Zając, M., & Hubáček, P. (2020) · medRxiv · doi:10.1101/2020.11.23.20237198 · Cited by 26
Almendares, O., Prince-Guerra, J. L., Nolen, L. D., Gunn, J. K. L., Dale, A. P., Buono, S. A., Deutsch-Feldman, M., Suppiah, S., Hao, L., Zeng, Y., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01742-21 · Cited by 26
The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients
Caruana, G., Lebrun, L., Aebischer, O., Opota, O., Urbano, L. A., Rham, M. D., Marchetti, O., & Greub, G. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100899 · Cited by 25
Drain, P. K., Sulaiman, R. A., Hoppers, M., Lindner, N. M., Lawson, V., & Ellis, J. E. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab173 · Cited by 25
Iglὁi, Z., Velzing, J., Huisman, R. C., GeurtsvanKessel, C. H., Comvalius, A., IJpelaar, J., van Beek, J., Ensing, R., Boelsums, T. L., Koopmans, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260894 · Cited by 25
Fernández‐González, M., Agulló, V., de la Rica, A., Infante, A., Carvajal, M., García, J. A., Gonzalo-Jiménez, N., Cuartero, C., Ruiz‐García, M., de Gregorio, C., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.03033-20 · Cited by 24
Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care
LeGoff, J., Kernéis, S., Elie, C., Mercier‐Delarue, S., Gastli, N., Choupeaux, L., Fourgeaud, J., Alby, M.-L., Quentin, P., Pavie, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00560-8 · Cited by 24
Pollock, N. R., Tran, K., Jacobs, J. R., Cranston, A. E., Smith, S., O’Kane, C. Y., Roady, T. J., Moran, A., Scarry, A., Carroll, M., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab243 · Cited by 24
Jakobsen, K. K., Jensen, J. S., Todsen, T., Lippert, F. K., Martel, C. J., Klokker, M., & von Buchwald, C. (2021) · medRxiv · doi:10.1101/2021.01.22.21250042 · Cited by 23
Kost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0716-sa · Cited by 23 · cited 1×
“Mathematical transformation of pre-test to post-test probability of COVID-19 [92,93] allows computation of RFO, the false omission rate [Equation (20), Table S5], and determination of the prevalence boundary (PB) [Equation (26)] in Supplementary Materials.”
BackgroundSelf-citationClinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Koeleman, J. G. M., Brand, H., de Man, S. J., & Ong, D. S. Y. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04274-7 · Cited by 22
Chiu, R. Y. T., Kojima, N., Mosley, G. L., Cheng, K. K., Pereira, D. Y., Brobeck, M., Chan, T. L., Zee, J. S., Kittur, H., Chung, C. Y. T., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00342-21 · Cited by 22
Diagnostic Strategies for Endemic Coronavirus Disease 2019 (COVID-19)
Kost, G. J. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0386-sa · Cited by 22 · cited 2×
“Mathematical transformation of pre-test to post-test probability of COVID-19 [92,93] allows computation of RFO, the false omission rate [Equation (20), Table S5], and determination of the prevalence boundary (PB) [Equation (26)] in Supplementary Materials.”
BackgroundMethodSelf-citationHolzner, C., Pabst, D., Anastasiou, O. E., Dittmer, U., Manegold, R. K., Riße, J., Fistera, D., Kill, C., & Falk, M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27033 · Cited by 21
Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2
Thell, R., Kallab, V., Weinhappel, W., Mueckstein, W., Heschl, L., Heschl, M., Korsatko, S., Toedling, F., Blaschke, A., Herzog, T., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259527 · Cited by 21
Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site
Ford, L., Whaley, M. J., Shah, M. M., Salvatore, P. P., Segaloff, H. E., Delaney, A. M., Currie, D. W., Boyle-Estheimer, L., O’Hegarty, M., Morgan, C. N., et al. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab081 · Cited by 20
Wang, H., Hogan, C. A., Verghese, M., Solis, D., Sibai, M., Huang, C., Zehnder, J. L., Sahoo, M. K., & Pinsky, B. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab063 · Cited by 19 · cited 6×
“In the Supplementary Materials at the end of this article, Table S1 lists EUA PPA and NPA claims.”
BackgroundInfluentialCOVID‐19 screening test by using random oropharyngeal saliva
Rao, M., Rashid, F. A., Sabri, F. S. A. H., Jamil, N. N., Seradja, V. H., Abdullah, N. A., Ahmad, H., Aren, S. L., Ali, S. A. S., Ghazali, M., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26773 · Cited by 18
Marx, G. E., Biggerstaff, B. J., Nawrocki, C. C., Totten, S. E., Travanty, E. A., Burakoff, A. W., Scott, T., Hey, J. C.-V. D., Carlson, J. J., Wendel, K. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab330 · Cited by 18
Diagnostic Accuracy of SARS-CoV-2 Antigen Detection Test in Children: A Real-Life Study
Jung, C., Lévy, C., Varon, E., Biscardi, S., Batard, C., Wollner, A., Deberdt, P., Sellam, A., Hau, I., & Cohen, R. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.647274 · Cited by 18
Jakobsen, K. K., Jensen, J. S., Todsen, T., Kirkby, N. S., Lippert, F. K., Vangsted, A., Klokker, M., & von Buchwald, C. (2021) · Apmis · doi:10.1111/apm.13189 · Cited by 18
Ollier, Q., Pillet, S., Mory, O., Gagnaire, J., Thuiller, C., Annino, N., Gagneux‐Brunon, A., Botelho-Nevers, É., Bourlet, T., Pozzetto, B., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.12.019 · Cited by 18
Shrestha, B., Neupane, A., Pant, S., Shrestha, A., Bastola, A., Rajbhandari, B., Thapa, A., & Singh, A. (2020) · Kathmandu University Medical Journal · doi:10.3126/kumj.v18i2.32942 · Cited by 17
Caruana, G., Croxatto, A., Kampouri, E., et al. (2021) · medRxiv · doi:10.1101/2021.02.10.21250915 · Cited by 17
Kernéis, S., Elie, C., Fourgeaud, J., et al. (2021) · medRxiv · doi:10.1101/2021.04.08.21255144 · Cited by 17
Nacher, M., Mergeay-Fabre, M., Blanchet, D., Benois, O., Pozl, T., Mesphoule, P., Sainte-Rose, V., Vialette, V., Toulet, B., Moua, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257169 · Cited by 17
Alghounaim, M., Bastaki, H., Essa, F. B., Motlagh, H., & Al-Sabah, S. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.797109 · Cited by 17
Cento, V., Renica, S., Matarazzo, E., Antonello, M., Colagrossi, L., Ruscio, F. D., Pani, A., Fanti, D., Vismara, C., Puoti, M., et al. (2021) · Viruses · doi:10.3390/v13050818 · Cited by 16
COVID-19 Antigen Testing: Better than We Know?
Homza, M., Zelená, H., Janošek, J., Tomášková, H., Ježo, E., Kloudová, A., Mrázek, J., Švagera, Z., & Prymula, R. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1914857 · Cited by 16 · cited 1×
“On the other hand, one report showed that ~92% of patients infected with SARS-CoV-2, but missed by antigen testing, contained no viable virus [96].”
BackgroundPerformance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL
der Moeren, N. V., Zwart, V. F., Goderski, G., Rijkers, G. T., van den Bijllaardt, W., Veenemans, J., Kluytmans, J. A. J. W., Pas, S. D., Meijer, A., Verweij, J. J., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104909 · Cited by 16
Kost, G. J. (2021) · PubMed Central · Cited by 16
Self-citationMore than the Eye Can See: Shedding New Light on SARS-CoV-2 Lateral Flow Device-Based Immunoassays
Koller, G., Morrell, A. P., Galão, R. P., Pickering, S., MacMahon, E. M. E., Johnson, J., Ignatyev, K., Neil, S. J. D., Elsharkawy, S., Fleck, R. A., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c04283 · Cited by 15
Burdino, E., Cerutti, F., Panero, F., Allice, T. G., Gregori, G., Milia, M. G., Cavalot, G., Altavilla, A., Aprà, F., & Ghisetti, V. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114337 · Cited by 15
Merrick, B., Noronha, M., Batra, R., Douthwaite, S. T., Nebbia, G., Snell, L. B., Pickering, S., Galão, R. P., Whitfield, J., Jahangeer, A., et al. (2021) · Infection Prevention in Practice · doi:10.1016/j.infpip.2021.100186 · Cited by 15
Alkhateeb, K. J., Cahill, M. N., Ross, A. S., Arnold, F. W., & Snyder, J. W. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115450 · Cited by 14
Denina, M., Giannone, V., Curtoni, A., Zanotto, E., Garazzino, S., Urbino, A., & Bondone, C. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02776-z · Cited by 14
Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting
Leixner, G., Voill‐Glaninger, A., Bonner, E., Kreil, A., Zadnikar, R., & Viveiros, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.063 · Cited by 12
Loconsole, D., Centrone, F., Morcavallo, C., Campanella, S., Sallustio, A., Casulli, D., Accogli, M., & Chironna, M. (2021) · BioMed Research International · doi:10.1155/2021/3893733 · Cited by 12
Fernández‐Montero, A., Argemí, J., Rodríguez, J. A., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3814781 · Cited by 10
Cable, R., Coleman, C., Glatt, T. N., Grebe, E., Mhlanga, L., Nyano, C., Pieterson, N., Swanevelder, R., Swarts, A., Sykes, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1359658/v1 · Cited by 10
Kost, G. J., & Zadran, A. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2019.029249 · Cited by 9
Self-citationKost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0443-sa · Cited by 9
Self-citationEvaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2Preprint
Thell, R., Kallab, V., Weinhappel, W., et al. (2021) · medRxiv · doi:10.1101/2021.04.22.21255637 · Cited by 9
Mungomklang, A., Trichaisri, N., Jirachewee, J., Sukprasert, J., Tulalamba, W., & Viprakasit, V. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0809 · Cited by 9
Lanari, M., Biserni, G. B., Pavoni, M., Borgatti, E. C., Leone, M., Corsini, I., & Lazzarotto, T. (2021) · Viruses · doi:10.3390/v13102071 · Cited by 9
Reichert, F., Enninger, A., Plecko, T., Zoller, W. G., & Paul, G. (2021) · American Journal of Infection Control · doi:10.1016/j.ajic.2021.07.009 · Cited by 8
Agarwal, J., Das, A., Pandey, P., Sen, M., & Garg, J. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.13925 · Cited by 8
Lopes, J. I. F., Silva, C. A. D. C., Cunha, R. G., Soares, A. M., Lopes, M. E., Neto, O. C. D. C., Alves, A. D. R., Coelho, W. L. D. C. N. P., Filho, L. A., & Leon, L. A. A. (2021) · Viruses · doi:10.3390/v13122361 · Cited by 8
Pollreis, R. E., Roscoe, C., Phinney, R., Malesha, S. S., Burns, M. C., Ceniseros, A., Washington, C. H., Nutting, A. J., & Ball, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260862 · Cited by 7
Kost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0563-le · Cited by 7 · cited 2×
“This initiative will add to the massive expansion of point-of-care strategies and promote higher quality molecular self-testing [1,2,104,105].”
BackgroundSelf-citationBalaska, S., Pilalas, D., Takardaki, A., Koutra, P., Parasidou, E., Gkeka, I., Tychala, A., Meletis, G., Fyntanidou, B., Metallidis, S., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11101766 · Cited by 6
Kost, G. J. (2022) · PubMed · doi:10.5858/arpa.2022-0037-le · Cited by 3 · cited 2×
“This initiative will add to the massive expansion of point-of-care strategies and promote higher quality molecular self-testing [1,2,104,105].”
BackgroundSelf-citationZadran, A., & Kost, G. J. (2019) · Journal of Hospital Management and Health Policy · doi:10.21037/jhmhp.2018.12.04 · Cited by 3
Self-citation
Research works printed but not linked: 3
- 4. Kost G.J., Ferguson W.J., Kost L.E. Principles of point of care culture, the spatial care path, and enabling community and global resilience. J. Int. Fed. Clin. Chem. Lab. Med. 2014;25:4–23.
- 5. Kost G.J., Ferguson W.J., Truong A.-T., Prom D., Hoe J., Banpavichit A., Kongpila S. The Ebola Spatial Care PathTM: Point-of-care lessons learned for stopping outbreaks. Clin. Lab. Int. 2015;39:6–14.
- 112. Eng M., Zadran A., Kost G.J. Covid-19 risk avoidance and management in limited-resource countries—Point-of-care strategies for Cambodia. Omnia Digital Health. June–July, 2021. [(accessed on 26 April 2022)]. pp. 112–115. Available online: https://secure.viewer.zmags.com/publication/44e87ae6?page=115&nocache=1625391874149&fbclid=IwAR2gIObRf6ThX15vlBpqMRYSC83hiZysJ8uMxEae7Em16bhOrnfEJTgNWuo#/44e87ae6/115.
Cited by
Point-of-care testing: state-of-the art and perspectives
Plebani, M., Nichols, J. H., Luppa, P. B., Greene, D., Sciacovelli, L., Shaw, J., Khan, A. I., Carraro, P., Freckmann, G., Dimech, W., et al. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0675 · Cited by 119
Self-citationBaldeh, M., Bawa, F. K., Bawah, F. U., Chamai, M., Dzabeng, F., Jebreel, W. M. A., Kabuya, J.-B. B., Dele-Olowu, S. K. M., Odoyo, E., Robinson, D. R., et al. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2277368 · Cited by 31
“…specific POCTs need to be in order to be useful, in which disease prevalence is a major consideration, but selection of molecular POCTs over other forms of rapid diagnostic test is often justified if high sensitivity and specificity are required for the situation in which they will be used [16,17].”
BackgroundOptimizing Public Health Preparedness for Highly Infectious Diseases in Central Vietnam
Zadran, A., Ho, A. V. D., Zadran, L., Curiel, I. J. V., Pham, T.-T., Thuan, D. T. B., & Kost, G. J. (2022) · Diagnostics · doi:10.3390/diagnostics12092047 · Cited by 11
“Point-of-care testing programs can be designed and implemented in rural and remote areas to educate and train healthcare staff on the use of RAgTs for infectious diseases [68].”
BackgroundSelf-citationKost, G. J., Füzéry, A. K., Caratao, L. K. R., Tinsay, S., Zadran, A., & Ybañez, A. P. (2023) · International Journal of Health Geographics · doi:10.1186/s12942-023-00359-y · Cited by 8
“A diagnostic portal is the geographic entry point from home to hospital where the patient self-tests or first seeks, obtains, or is administered diagnostic testing to rule in or rule out a medical condition and then expeditiously receives care [8].”
BackgroundInfluentialSelf-citationWeb-accessible critical limits and critical values for urgent clinician notification
Kost, G. J., Dohner, J., Liu, J., Ramos, D., Haider, N., & Thalladi, V. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0117 · Cited by 7
“%) likely bene fi t from enhanced awareness, accelerated infection control, and mitigated contagion [25, 26].”
Self-citation
Metadata
- Authors
- Kost, G. J.
- Affiliations
- University of California, Davis (US)
- Corresponding author
- Kost, Gerald J.
- ORCID
- Kost, Gerald J.
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2022-05-12
- Volume
- 12
- Issue
- 5
- Pages
- 1216
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC9140623
- OpenAlex
- W4280647568
- Cited by
- 13
- References
- 111
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 3 · 2022: 4
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Point-of-Care Testing Center for Teaching and Research (POCT•CTR)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, rapid antigen test, molecular diagnosis, diagnostic performance, prevalence threshold, home testing, self-testing, emergency department testing, community-based testing, missed diagnosis, asymptomatic infection, saliva testing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.